Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Chronic hepatitis B infection: a review
LSY Tang, E Covert, E Wilson, S Kottilil - Jama, 2018 - jamanetwork.com
Importance More than 240 million individuals worldwide are infected with chronic hepatitis B
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
慢性乙型肝炎防治指南(2010 年版)
贾继东， 李兰娟 - 肝脏, 2011 - cqvip.com
慢性乙型肝炎防治指南(2010年版)-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车 充值
客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 …
客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 …
慢性乙型肝炎防治指南(2015 年更新版)
王贵强， 王福生， 成军， 任红， 庄辉， 孙剑， 李兰娟… - 中国病毒病杂志, 2015 - cqvip.com
< 正> 本指南为规范慢性乙型肝炎(CHB) 的预防, 诊断和抗病毒治疗而制订, 涉及CHB
其他治疗方法和策略请参阅相关的指南和共识. 中华医学会肝病学分会和感染病学分会于2005 …
其他治疗方法和策略请参阅相关的指南和共识. 中华医学会肝病学分会和感染病学分会于2005 …
Cancer‐associated fibroblast‐mediated cellular crosstalk supports hepatocellular carcinoma progression
M Song, J He, QZ Pan, J Yang, J Zhao, YJ Zhang… - …, 2021 - Wiley Online Library
Background and Aims Cancer‐associated fibroblasts (CAFs) are key players in multicellular,
stromal‐dependent alterations leading to HCC pathogenesis. However, the intricate …
stromal‐dependent alterations leading to HCC pathogenesis. However, the intricate …
Getting to HBV cure: The promising paths forward
S Fung, HSJ Choi, A Gehring, HLA Janssen - Hepatology, 2022 - journals.lww.com
Chronic HBV infection is a global public health burden estimated to impact nearly 300
million persons worldwide. Despite the advent of potent antiviral agents that effectively …
million persons worldwide. Despite the advent of potent antiviral agents that effectively …
[PDF][PDF] A ASLD guidelines for treatment of chronic hepatitis B
NA Terrault, NH Bzowej, KM Chang, JP Hwang… - …, 2016 - Wiley Online Library
A<fc>ASLD</fc> guidelines for treatment of chronic hepatitis <fc>B</fc> Page 1 PRACTICE
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …
[HTML][HTML] Tenofovir to prevent hepatitis B transmission in mothers with high viral load
CQ Pan, Z Duan, E Dai, S Zhang, G Han… - … England Journal of …, 2016 - Mass Medical Soc
Background Few data are available regarding the use of tenofovir disoproxil fumarate (TDF)
during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus …
during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus …
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double …
Background The novel prodrug tenofovir alafenamide delivers the nucleotide reverse
transcriptase inhibitor tenofovir to target cells more efficiently at a lower dose than tenofovir …
transcriptase inhibitor tenofovir to target cells more efficiently at a lower dose than tenofovir …
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3 …
Background Tenofovir alafenamide is a novel prodrug formulated to deliver the active
metabolite to target cells more efficiently than tenofovir disoproxil fumarate at a lower dose …
metabolite to target cells more efficiently than tenofovir disoproxil fumarate at a lower dose …